Sort
23,748 grants matching “melanoma”
Immunology of human malignant melanoma initiating cells
$401,127Markus H. Frank · Boston Children'S Hospital · R01 · FY2012 · CA
GCDH Addiction in Melanoma
$401,077Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA
Tissue Management Shared Resource
$401,014Adam Yopp · Ut Southwestern Medical Center · P30 · FY2022 · CA
Tissue Management Shared Resource
$401,014Adam Yopp · Ut Southwestern Medical Center · P30 · FY2021 · CA
Tissue Management Shared Resource
$401,014Adam Yopp · Ut Southwestern Medical Center · P30 · FY2023 · CA
Tissue Management Shared Resource
$401,014Adam Yopp · Ut Southwestern Medical Center · P30 · FY2024 · CA
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ
$400,995David J Mooney · Harvard University · R01 · FY2019 · CA
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
$400,910Wei Dai · New York University School Of Medicine · R01 · FY2016 · ES
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
$400,910Wei Dai · New York University School Of Medicine · R01 · FY2012 · ES
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
$400,910Wei Dai · New York University School Of Medicine · R01 · FY2015 · ES
In situ radioimmunotherapy to maximize the engagement of conventional type 1 dendritic cells against non-T cell-inflamed tumors
$400,868Fumito Ito · University Of Southern California · R01 · FY2023 · CA
UNCOVERING THE ROLE OF BMP SIGNALING IN MELANOCYTE DEVELOPMENT AND MELANOMA TUMORIGENESIS
$400,800University Of Massachusetts Medical School · · FY2013 · Department of Defense
Isolation, Characterization, and Behavior of Melanocyte Stem Cells
$400,649Thomas J Hornyak · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Determinants of Melanocyte Transformation and Melanoma Progression
$400,649Thomas J Hornyak · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Project 3: Predicting therapeutic sensitivity in cancer
$400,638Anna Lasorella · Columbia University Health Sciences · U54 · FY2016 · CA
A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells
$400,514Jonathan P Schneck · Johns Hopkins University · R33 · FY2020 · CA
A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells
$400,511Jonathan P Schneck · Johns Hopkins University · R33 · FY2021 · CA
Cell intrinsic and extrinsic effects of zinc metabolism in therapy resistant melanoma
$400,461Katherine Marie Aird · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Analysis of the Signaling and Mechanical Cues Promoting Invasion in Melanoma
$400,424Andre Levchenko · Johns Hopkins University · U01 · FY2012 · CA
Targeting Lag-3 and PD -1 in Myeloid Cells of GBM
$400,345Michael Lim · Stanford University · R01 · FY2023 · NS
Development of anti-angiogenesis therapy targeting integrin
$400,331Zhi-Ren Liu · Georgia State University · R01 · FY2015 · CA
Genetic Epidemiology of Glioma International Consortium
$400,329Melissa L Bondy · Baylor College Of Medicine · R01 · FY2010 · CA
Targeting ATP-citrate lyase (ACLY) to overcome therapy resistance in breast cancer and melanoma
$400,241Nancy A Krucher · Pace University New York · R15 · FY2023 · CA
In vivo murine models of metastasis for therapeutic testing
$400,209Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · R01 · FY2015 · CA
In vivo murine models of metastasis for therapeutic testing
$400,209Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA